Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin pharmacokinetics during cardiac surgery with albumin versus crystalloid bypass priming
2020-002756-21Phase 4Terminated
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2021
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefazolin and albumin (human) in bacterial disease (2 arms), sponsored by Medical University of South Carolina. Primary endpoint: Area under the concentration-time curve. Started Jan 2021; status: terminated.
02
Drugs
cefazolinalbumin (human)
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2020-002756-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002756-21.